Related Experiment Video
Updated: Jul 12, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Robotic mitral valve surgery: a United States multicenter trial
L Wiley Nifong1, W R Chitwood, P S Pappas
1Brody School of Medicine at East Carolina University, Pitt County Memorial Hospital, Greenville, NC, USA. nifongL@mail.ecu.edu
The Journal of Thoracic and Cardiovascular Surgery
|June 9, 2005
Summary
Robotic mitral valve repair in 112 patients demonstrated safety and feasibility in a phase II trial. Early results show a low reoperation rate, highlighting potential for minimally invasive cardiac surgery.
Area of Science:
- Cardiovascular Surgery
- Minimally Invasive Techniques
- Robotic Surgery
Background:
- Mitral regurgitation is a significant cardiac condition requiring effective treatment.
- Robotic-assisted surgery offers potential for enhanced precision in complex cardiac procedures.
Purpose of the Study:
- To evaluate the safety and efficacy of robotic mitral valve repair.
- To assess the feasibility of this minimally invasive technique in a multi-center trial.
Main Methods:
- Prospective phase II Food and Drug Administration (FDA) trial involving 112 patients.
- Robotic mitral valve repair using the da Vinci surgical system.
- Standardized technique including peripheral cardiopulmonary bypass and minithoracotomy.
Main Results:
- Successful repair (grade 0 or 1 mitral regurgitation) achieved in the majority of patients at 1 month.
- Low incidence of reoperation (5.4%) with no deaths or strokes.
- Average operative times for robotic components were recorded.
Conclusions:
- Robotic mitral valve repair is a safe and feasible early-stage procedure.
- Further advancements in robotic technology may optimize operative times and outcomes.
- This minimally invasive approach shows promise for treating mitral regurgitation.
Related Concept Videos
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:20Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:22Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...